HP CEO Emma Walmsley: Ex-GSK Chief to Lead PC Maker From January

A pharma veteran takes over a PC maker

HP Inc. has picked its next permanent chief executive from outside the technology hardware business. The board voted unanimously to appoint Emma Walmsley, who ran GSK and sits on Microsoft's board, as CEO. The appointment was announced from the company's Palo Alto, California, headquarters on November 4, 2026, and takes effect on January 4, 2027.11 The decision ends a leadership gap that began when Enrique Lores left HP in February to run PayPal.1 Bruce Broussard has been interim CEO since then and will hand over day-to-day control when Walmsley starts.5

The boardroom is changing at the same time. On the day Walmsley takes over, Broussard becomes chair of the board, replacing Chip Bergh. Bergh has chaired HP since 2017 and has been a director since 2015.11 HP described the arrangement as a planned handoff, and the release gives no reason for Bergh's departure other than the transition itself.15

The main facts are consistent across the coverage: who was hired, the start date, and how the board will look afterward. The reporting splits on what kind of bet this is and whether the governance setup behind it holds up.

Who Emma Walmsley is

Walmsley is 57 and was born in Barrow-in-Furness in northwest England. Her father, Robert Walmsley, was a Royal Navy officer who later became the UK's chief of defence procurement. She studied classics and modern languages at Oxford.6 She spent 17 years at L'Oréal in marketing and management jobs in London, Paris, New York and Shanghai, and eventually ran the company's consumer products business in China, which included Maybelline and Garnier.16

She joined GSK in 2010 and became CEO of its consumer healthcare unit in 2015. In April 2017 she was named group chief executive, the first woman to lead the British drugmaker.116 Her nearly nine years in charge included the spin-off of the consumer health business as Haleon, the COVID-19 pandemic, Unilever's unsuccessful bid for the consumer assets, and pressure from the activist investors Elliott and Bluebell.6 She left GSK at the end of 2025.6 She was made a Dame Commander of the Order of the British Empire in 2020 and has been a Microsoft director for seven years.

Two very different accounts of her GSK record

HP's own description of her time at GSK is very positive. The company says she produced a "step-change" in operating performance, revived the R&D pipeline, sharpened the focus on specialty medicines and vaccines, and strengthened the balance sheet after the consumer health separation.12 Most trade write-ups repeat that account with little change.9

Independent reporting is more critical. Reuters noted that investors sometimes doubted the strength of GSK's drug pipeline under her.6 Boardroom Alpha went further and measured returns. It found GSK's US-listed shares returned about 71% with dividends reinvested from her first day to her last, compared with roughly 233% for the S&P 500. That ranks ninth out of 12 large drugmakers in its comparison.4 The same analysis recalls that in 2021 Elliott pushed GSK's board to consider outside candidates for the top job, and the board publicly backed her the next day.4

Both accounts are accurate, and they measure different things. Walmsley's strongest results at GSK were structural: splitting up a conglomerate, refocusing its portfolio and keeping control through activist pressure. Shareholder returns were weaker. HP's board appears to have hired her for the first set of skills.

Why HP needed an outsider now

She arrives at a hard moment. Reuters reported that HP faces a memory-chip shortage that has pushed up prices and caused a sharp industry downturn. AI data center construction is absorbing much of the available memory supply, and Dell, Apple and Lenovo are under the same pressure.7 HP has said it will not give a fiscal 2027 outlook and expects industry PC unit volumes to fall by a mid-single-digit percentage next year.7

HP's own numbers add to the challenge. According to Boardroom Alpha, printing produced 28% of revenue but 59% of profit from the two main segments in the first nine months of the fiscal year, and printing revenue is falling. A restructuring approved in November 2025 is set to cut 4,000 to 6,000 jobs by the end of fiscal 2028.4 The new CEO will lead a company whose most profitable business is shrinking while its larger business depends on an unstable component supply.

Walmsley's first public comments focused on AI. She said HP would work to harness "the power of the AI era" and find new sources of growth.12 Broussard said she was the right person to bring the company's businesses together "as AI moves to the edge."12 That refers to AI-capable PCs and connected devices that run workloads locally instead of in the cloud.3 Reuters pointed out that she takes over with no previous experience in tech hardware.7

This looks like a conglomerate-management hire more than a product hire. A CEO who separated a large consumer business from a pharmaceutical parent has relevant experience for a company with distinct PC, printing and services operations. That background will be useful if HP's board later considers restructuring the company.

The governance questions

Governance is where the coverage differs most. The press release and most news reports present Broussard's move to chair as continuity. Bergh said Broussard would give "important continuity and valuable guidance" to Walmsley and the board.11

Boardroom Alpha was more skeptical. In February, HP's proxy said Broussard was not independent because he was serving as interim CEO. The same proxy opposed a shareholder proposal to require an independent chair, which got only 16.1% support, while noting that HP had had an independent chair since 2017.4 The analysis argues that a chair who was CEO until the day his successor starts is not an obvious check on her. It also says the announcement does not name a lead independent director.4 It reported that Broussard received a second stock award on October 30, the day before the announcement filing, and that no explanation was given.4

The Microsoft seat raises a further question. HP's annual report lists Microsoft as one of the main competitors to its PC business and also as a key software supplier. Microsoft's October proxy nominated Walmsley for re-election at its December 8 annual meeting.4 HP's announcement mentions her Microsoft directorship but does not say whether she will keep it. HP's bylaws restrict directors who have served at competitors from sitting on its board, and the board changed its definition of a competitor in June without public explanation.4 Whether she joins HP's board, as Lores did, will show how the company resolves this.

These are reasonable questions, not signs of wrongdoing. HP has had a non-independent chair before, under Meg Whitman from 2015 to 2017.4 Still, the board argued in February that an independent chair served shareholders best, and it has not explained why it changed its view.

How the market reacted

Early reports of the stock reaction did not match the close. One outlet reported HP shares down about 1% to 2% in pre-market trading.18 By the end of the day the stock had gained 4.42% to $29.52, which one report attributed to relief that the leadership question had been settled.14 Before the announcement the shares were up about 32% for the year but down roughly 20% since mid-September.4 The full-day gain gives a better picture of investor sentiment than the early drop, but a one-day move says little about how a CEO will perform.

What comes next

Several dates will show how the transition starts. HP reports fourth-quarter results on November 24, the last earnings release before Walmsley arrives.14 Microsoft's December 8 meeting will show whether she keeps her seat there.4 Investors are also waiting for a filing on her pay package and any changes to her board roles.4

In one sense, HP has chosen a CEO with experience reshaping a large, complicated company under pressure, which is the job ahead. The open issues are her record on shareholder returns, a chair whose independence is unclear, and a seat on the board of a company HP lists as a rival. How she handles the memory shortage and the decline in printing in 2027 will determine whether HP's board made the right call.